Ian Read, chairman and CEO of Pfizer, is elected chairman of the PhRMA.

CBER will move to the FDA White Oak campus in Silver Spring, Maryland.

Aesica's consortium project receives grant to investigate an industrial biotechnology process to improve the manufacturing of an API.

FDA develops an assay that could speed the release of pandemic influenza vaccines.

Fette Compacting America appoints Sean Scully as its new president.

The Advanced Tissue-engineered Human Ectypal Network Analyzer project team is developing realistic human organs for testing.

Molecular Profiles expands technology with GMP hot melt extrusion.

uniQure appoints a new COO and vice president, Medical affairs.

Takeda Pharmaceuticals and Eli Lilly announced that they plan to challenge a $9 billion judgment in a lawsuit that alleged Actos caused a patient's bladder cancer.

European scientists have discovered a method to improve the efficiency of the pharmaceutical production through plant biotechnology.

Dalton Pharma completes its $2.5 million expansion in Toronto for sterile and aseptic filling capabilities.

Sun Pharma acquisition of Ranbaxy Laboratories will create the fifth-largest specialty generics company in the world.

Merck promotes internal managers to head Merck Millipore and Consumer Health Divisions.

FDA approves Oralair, the first sublingual allergen extract for the treatment of pollen allergies.

EDQM has launched a database, Know-X, which collates reports on counterfeit/falsified medical products that have been detected in Council of Europe member states.

Evzio, the first naloxone treatment specifically designed to administered to opioid overdose patients by family members or caregivers, approved in 15 weeks.

More media options open publishing opportunities for drug development experts.

Carolina Medical Products changes its name to CMP Pharma to reflect current business trends.

GSK recalls alli weight loss products in the US and Puerto Rico.

The I'm In campaign is designed to increase participation by diverse patient populations for clinical trials.

FDA has announced Fresenius Kabi USA, LLC of Lake Zurich, Ill., will temporarily distribute normal saline in the United States from its Norway manufacturing facility.

Covance adds workspace and scientists to biologics team in Indianapolis facility.

Vetter launches new serialization process to support track-and-trace efforts.

RCA opens a new office in Warsaw, Poland.

AmerisourceBergen to establish a joint venture for specialty distribution with Profarma.

Baxter announces plans to split into two independent companies by mid-2015.

Pfizer intends to submit a biologics license application for its investigational Meningococcal B vaccine candidate, Bivalent rlp2086, to FDA by mid-2014.

Catalent increases its minority investment in Redwood Bioscience for engineering ADCs.